11 Alzheimers Disease Clinical Trials in Santa Rosa, CA (2026)

Q: How do I join a clinical trial in Santa Rosa?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Rosa research site will contact you.

Recruiting Alzheimers Disease Studies in Santa Rosa

NCT06129864Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

The main purpose of this study is to assess the efficacy and safety of volrustomig compared to observation in participants with unresected locally advanced head and neck squamous cell carcinoma (LA-HN...

Santa Rosa, CAPHASE31,145 participantsAstraZeneca

View Study Details

NCT05579366Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid tumor cancer that ha...

Santa Rosa, CAPHASE1884 participantsGenmab

View Study Details

NCT07602582Recruiting

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 ye...

Santa Rosa, CAPHASE3550 participantsEli Lilly and Company

View Study Details

NCT03093116Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and recommended Phase 2 dose (RP2D) of repotre...

Santa Rosa, CAPHASE1500 participantsTurning Point Therapeutics, Inc.

View Study Details

NCT07106762Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

A Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or After Immunotherapy...

Santa Rosa, CAPHASE2470 participantsBristol-Myers Squibb

View Study Details

NCT05123482Recruiting

A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies

This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents...

Santa Rosa, CAPHASE1460 participantsAstraZeneca

View Study Details

NCT05489211Recruiting

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer Agents in Patients with Ad...

Santa Rosa, CAPHASE2454 participantsAstraZeneca

View Study Details

NCT07277413Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

This is a multicenter clinical study to evaluate the safety, efficacy, and Pharmacokinetics (PK) of IDE892 as monotherapy and in combination with other agents including IDE397 in participants with met...

Santa Rosa, CAPHASE1260 participantsIDEAYA Biosciences

View Study Details

NCT03556228Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

This is a multicenter, open-label, Phase 1/2 study of orally administered VMD-928 monotherapy and in combination with pembrolizumab in adult subjects with advanced solid tumors or lymphoma that have p...

Santa Rosa, CAPHASE1242 participantsVM Oncology, LLC

View Study Details

NCT06219941Recruiting

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

The purpose of this study is to assess the safety, tolerability, efficacy, pharmacokinetics (PK), and immunogenicity of AZD0901 as monotherapy and in combination with anti-cancer agents in participant...

Santa Rosa, CAPHASE2224 participantsAstraZeneca

View Study Details

NCT07002034Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adj...

Santa Rosa, CAPHASE2100 participantsReunion Neuroscience Inc

View Study Details

About Alzheimers Disease Clinical Trials in Santa Rosa

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 11 alzheimers disease clinical trials recruiting participants in Santa Rosa, CA. These studies are seeking a combined 5,289 participants. Research is being sponsored by AstraZeneca, Genmab, Eli Lilly and Company and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Santa Rosa — FAQ

Are there alzheimers disease clinical trials in Santa Rosa?

Yes, there are 11 alzheimers disease clinical trials currently recruiting in Santa Rosa, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Rosa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Rosa research site will contact you about next steps.

Are clinical trials in Santa Rosa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Rosa studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 11 active trials in Santa Rosa are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 22, 2026 from ClinicalTrials.gov